Every practitioner using these products is going to deal with one or more Medicare auditors.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

It is unfortunate that an opportunity to understand the impact of Semaglutide on diabetic foot ulcers was entirely lost.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Here’s a guest blog from Michael Crouch, following up on Martha Kelso’s post about audit requirements.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Lives are at stake, so let us never relax in our commitment to safety and excellence in the practice of Hyperbaric Medicine.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Check out Knicole Emanuel’s recent blog post about CMS monetary recoupment before full adjudication.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

A heads-up about the documentation demands for a recent audit of CTPs/CAMPs/skin substitutes – this time a UPIC audit.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Check out Jeanne Pinder’s newest Clear Health Costs article about the “skin substitute” market.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

An article in JAMA Dermatology reviews the wound characteristics of a series of 29 patients hospitalized with confirmed xylazine exposure.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

It’s easy to find out if a specific chamber has been cleared by the FDA, and to report illegal activities to the FDA (keep reading).

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.

Maybe at the very least, we can encourage patients to talk to their primary care doctor about trying a Glucagon-like peptide 1 receptor.

The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.